For U.S. Healthcare Professionals Only

Type:
A A A

In the treatment of type 2 diabetes Are you up for the Glycemic Explorer Challenge?

Take the challenge

TARGET PHYSIOLOGIC ABNORMALITIES IN T2DM

See how different medication classes affect various organs in this interactive activitySTART NOW

WATCH VIDEOS BY EXPERTS IN T2DM

Dr. Vivian Fonseca and other key thought leaders explore different approaches to T2DM managementWATCH NOW

T2DM is a complex disease, with multiple physiologic abnormalities.1 Currently, many patients with T2DM are not reaching their individualized glycemic goal.2,3,*

Will your next move do enough?

Guidelines by the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE) recommend healthy eating, weight control, increased physical activity, and diabetes education as a foundation for T2DM management throughout the course of treatment.3,4

T2DM=type 2 diabetes mellitus

*Glycated hemoglobin (HbA1c) targets are individualized for each patient; for non-pregnant, healthy adults, the ADA recommends an HbA1c target of <7.0%.2

References:

1. Ferrannini E, DeFronzo RA. Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes. Eur Heart J. 2015;36(34):2288-2296. 2. Ali MK, Bullard KM, Saaddine JB, et al. Achievement of goals in U.S. diabetes care. 1999-2010. N. Engl J Med. 2013;368:1613-1624. doi:10.1056/NEJMsa1213829. 3. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2016;39(Suppl 1):S1–S112. 4. Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of Clinical Endocrinologists and the American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2016 executive summary. Endocr Pract. 2016;22(1):84-113.